(Q50584701)

16 March 2018

title

Fractalkine (CX3CL1): a biomarker reflecting symptomatic severity in patients with knee osteoarthritis. (English)

1 reference

16 March 2018

1 reference

1 reference

Li Wei Huo

1

1 reference

16 March 2018

Yong Liang Ye

series ordinal

2

1 reference

16 March 2018

Guang Wei Wang

series ordinal

3

1 reference

16 March 2018

Yong Guang Ye

series ordinal

4

1 reference

16 March 2018

publication date

1 April 2015

1 reference

16 March 2018

Journal of Investigative Medicine

published in

1 reference

16 March 2018

volume

63

1 reference

16 March 2018

issue

4

1 reference

16 March 2018

page(s)

626-631

1 reference

16 March 2018

The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study

cites work

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Osteoarthritis: an update with relevance for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Synovial tissue inflammation in early and late osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Circulating levels of IL-6 and TNF-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

21 January 2018

Chemokines and disease

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

The chemokine superfamily revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

A new class of membrane-bound chemokine with a CX3C motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of mitogen-activated protein kinases and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Quantitative genetic study of amphiregulin and fractalkine circulating levels--potential markers of arthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Correlation of fractalkine concentrations in serum and synovial fluid with the radiographic severity of knee osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Fractalkine/CX3CR1 signalling in chronic pain and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Metabolic syndrome and the functional outcomes of hip and knee arthroplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Radiological assessment of osteo-arthrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Recent advances in biomarkers in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Immunopathogenesis of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Biologic agents in osteoarthritis: hopes and disappointments

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

The role of synovitis in osteoarthritis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Clinical assessment and significance of inflammation in knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Chemokines and chemokine receptors in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Overview of the mechanisms regulating chemokine activity and availability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Chemokine research moves on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Inhibition of fractalkine ameliorates murine collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Inflammatory diseases of the bones and joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

In vivo structure/function and expression analysis of the CX3C chemokine fractalkine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

Inflammation and angiogenesis in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FJIM.0000000000000158

10.1097/JIM.0000000000000158

21 January 2018

Identifiers

DOI

1 reference

16 March 2018

PubMed ID

25692263

1 reference

16 March 2018